Log in to save to my catalogue

Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT 2a Receptor Antagonists

Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT 2a Receptor Antagonists

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32385739

Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT 2a Receptor Antagonists

About this item

Full title

Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT 2a Receptor Antagonists

Publisher

New Zealand

Journal title

Drugs (New York, N.Y.), 2020-06, Vol.80 (9), p.871

Language

English

Formats

Publication information

Publisher

New Zealand

More information

Scope and Contents

Contents

Akathisia is one of the most prevalent and distressing adverse effects associated with antipsychotic drug treatment. Propranolol, a non-selective beta-adrenergic receptor antagonist, is currently considered a first-line treatment for antipsychotic-induced akathisia (AIA). Surprisingly, the evidence for its anti-akathisia effect is modest. Propranol...

Alternative Titles

Full title

Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT 2a Receptor Antagonists

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_32385739

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32385739

Other Identifiers

E-ISSN

1179-1950

DOI

10.1007/s40265-020-01312-0

How to access this item